ReviewESMO open2016

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma.

Alejo Rodriguez-Vida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.